More than nine out of 10 scientists who backed a drug at the centre of a safety scare had financial links to the pharmaceutical industry, a study has found.
The disclosure will renew concern about the influence of the multinational companies on patient safety, where a warning about a drug can wipe billions from their balance sheets.
The pharmaceutical industry has become adept at manipulating results and selectively withholding unfavourable data that could expose patients to harm. Now it is accused of skewing the debate over one drug, Avandia, prescribed to millions of people around the world with Type 2 diabetes. Avandia, made by the British multinational GlaxoSmithKline (GSK), which helps diabetics control their blood sugar levels, was linked with an increased risk of heart attacks in research published in 2007.
New guidelines for managing cholesterol call for more aggressive prevention and earlier treatment, including a recommendation...
